blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1809241

EP1809241 - DYE-FREE PHARMACEUTICAL SUSPENSIONS COMPRISING ACETAMINOPHEN [Right-click to bookmark this link]
Former [2007/30]DYE-FREE PHARMACEUTICAL SUSPENSIONS AND RELATED METHODS
[2011/10]
StatusNo opposition filed within time limit
Status updated on  08.06.2012
Database last updated on 16.07.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): PT		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
McNeil-PPC, Inc.
Grandview Road Skillman
New Jersey 08558 / US
[2011/31]
Former [2007/30]For all designated states
McNEIL-PPC, Inc.
Grandview Road Skillman
New Jersey 08558 / US
Inventor(s)01 / BUEHLER, Gail, K.
1111 Hunt Seat Drive
Lower Gwynedd, PA 19002 / US
 [2007/30]
Representative(s)Kirsch, Susan Edith, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2007/30]Kirsch, Susan Edith, et al
Carpmaels & Ransford 43-45 Bloomsbury Square
LONDON WC1A 2RA / GB
Application number, filing date05818055.527.10.2005
[2007/30]
WO2005US39348
Priority number, dateUS2004097803529.10.2004         Original published format: US 978035
[2007/30]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006050302
Date:11.05.2006
Language:EN
[2006/19]
Type: A2 Application without search report 
No.:EP1809241
Date:25.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 11.05.2006 takes the place of the publication of the European patent application.
[2007/30]
Type: B1 Patent specification 
No.:EP1809241
Date:03.08.2011
Language:EN
[2011/31]
Search report(s)International search report - published on:EP15.02.2007
ClassificationIPC:A61K9/00, A61K31/167
[2007/30]
CPC:
A61K9/0095 (EP,US); A61K9/10 (KR); A61K31/167 (KR);
A61P29/00 (EP); A61P37/06 (EP); A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/30]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:FARBSTOFFFREIE PHARMAZEUTISCHE SUSPENSIONEN ENTHALTEND ACETAMINOPHEN[2011/10]
English:DYE-FREE PHARMACEUTICAL SUSPENSIONS COMPRISING ACETAMINOPHEN[2011/10]
French:SUSPENSIONS PHARMACEUTIQUES SANS COLORANT CONTENANT DE L' ACETAMINOPHENE[2011/10]
Former [2007/30]FARBSTOFFFREIE PHARMAZEUTISCHE SUSPENSIONEN UND ZUGEHÖRIGE VERFAHREN
Former [2007/30]DYE-FREE PHARMACEUTICAL SUSPENSIONS AND RELATED METHODS
Former [2007/30]SUSPENSIONS PHARMACEUTIQUES SANS COLORANT ET METHODES CONNEXES
Entry into regional phase24.05.2007National basic fee paid 
24.05.2007Designation fee(s) paid 
24.05.2007Examination fee paid 
Examination procedure24.05.2007Amendment by applicant (claims and/or description)
24.05.2007Examination requested  [2007/30]
19.06.2008Despatch of a communication from the examining division (Time limit: M04)
28.10.2008Reply to a communication from the examining division
26.01.2011Date of oral proceedings
07.02.2011Minutes of oral proceedings despatched
22.02.2011Communication of intention to grant the patent
09.06.2011Fee for grant paid
09.06.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.06.2008
Opposition(s)04.05.2012No opposition filed within time limit [2012/28]
Fees paidRenewal fee
24.05.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
13.10.2009Renewal fee patent year 05
12.10.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
DK03.08.2011
EE03.08.2011
FI03.08.2011
HU03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
PT03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
TR03.08.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG03.11.2011
GR04.11.2011
IS03.12.2011
[2014/34]
Former [2013/45]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
DK03.08.2011
EE03.08.2011
FI03.08.2011
HU03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
TR03.08.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG03.11.2011
GR04.11.2011
IS03.12.2011
Former [2013/44]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
DK03.08.2011
EE03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
TR03.08.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG03.11.2011
GR04.11.2011
IS03.12.2011
Former [2013/29]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
DK03.08.2011
EE03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG03.11.2011
GR04.11.2011
IS03.12.2011
Former [2013/25]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
DK03.08.2011
EE03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
GR04.11.2011
IS03.12.2011
Former [2012/33]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
DK03.08.2011
EE03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
GR04.11.2011
IS03.12.2011
Former [2012/25]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
EE03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
MC31.10.2011
GR04.11.2011
IS03.12.2011
Former [2012/23]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
EE03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
RO03.08.2011
SI03.08.2011
SK03.08.2011
GR04.11.2011
IS03.12.2011
Former [2012/21]AT03.08.2011
BE03.08.2011
CY03.08.2011
CZ03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
SI03.08.2011
GR04.11.2011
IS03.12.2011
Former [2012/17]AT03.08.2011
BE03.08.2011
CY03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
SI03.08.2011
GR04.11.2011
IS03.12.2011
Former [2012/12]AT03.08.2011
CY03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
SI03.08.2011
GR04.11.2011
IS03.12.2011
Former [2012/11]AT03.08.2011
FI03.08.2011
LT03.08.2011
LV03.08.2011
NL03.08.2011
SI03.08.2011
GR04.11.2011
IS03.12.2011
Former [2012/10]FI03.08.2011
LT03.08.2011
NL03.08.2011
GR04.11.2011
IS03.12.2011
Former [2012/09]FI03.08.2011
LT03.08.2011
NL03.08.2011
IS03.12.2011
Former [2012/08]LT03.08.2011
NL03.08.2011
IS03.12.2011
Cited inInternational search[XY]US4427681  (MUNSHI MAYANK V [US]) [X] 1-3,5-19,21-33 * column 1, line 56 - column 3, line 7 * * column 3, lines 26-30; examples 1,2,5-8; claims 1-8 * [Y] 4,20,34,35;
 [XY]US5112604  (BEAURLINE JOSEPH M [US], et al) [X] 1-3,5,6,13-16 * column 3, lines 49-54; examples 3,4 * [Y] 4,7,8,10-12;
 [X]US5354556  (SPARKS RANDALL T [US], et al) [X] 1,2,13-15,17,18,20,29-32 * examples 1,2,13,16 *;
 [XY]EP0620001  (MCNEIL PPC INC [US]) [X] 1-8,10-24,26-35 * the whole document * [Y] 7,8,10-12;
 [X]WO9500133  (IBAH INC [US]) [X] 1,2,13-15,17,18,30-32 * page 4, lines 16-28 * * page 5, line 11 - page 6, line 24 * * page 7, lines 20,21 *;
 [XY]EP0717992  (MCNEIL PPC INC [US]) [X] 1-3,13-15,17-19,30-32 * the whole document * [Y] 4,20,34,35;
 [XYI]EP0843998  (LEETRIM LTD DUBLIN [GB], et al) [X] 1-4,13-15 * column 1, paragraph 1 * * column 2, paragraphs 3-5; examples 2,3 * [Y] 4,20,34,35 [I] 5;
 [PXL]WO2005044230  (MCNEIL PPC INC [US], et al) [PXL] 1,2,13-15,17,18,29-32 * L: priority; page 11, lines 24-38 * * page 12, line 8 - page 14, line 15; example 3 *;
 [T]  - KIBBE AH, Handbook of Pharmaceutical Excipients, WASHINGTON D.C., APHA, (2000), XP002400921 [T] * "Coloring Agents"; page 146 - page 147 *
by applicantUS4427681
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.